08:44 AM EDT, 05/19/2026 (MT Newswires) -- Incyte ( INCY ) and Edison Scientific said Tuesday they are collaborating to deploy Edison's Kosmos AI platform across Incyte's ( INCY ) drug discovery and development workflow.

The companies said Kosmos will help analyze translational and clinical data, build predictive models of therapeutic performance, and support research decisions across Incyte's ( INCY ) development pipeline.

The initial rollout will focus on target discovery, validation, and translational biology, with potential expansion across Incyte's ( INCY ) broader research and development operations, they added.